Introduction The world is witnessing the spread of one of the members of Coronaviruses
(CoVs) family, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the …

Since the outbreak of corona virus disease 2019 (COVID-19) in Wuhan (China) in
December 2019, the epidemic has rapidly spread to many countries around the world …

Over 57 million people have been confirmed to have coronavirus disease 2019 (COVID-19)
worldwide. Although several drugs have shown potential therapeutic effects, there is no …

The highly transmissible SARS-CoV-2, the virus that causes COVID-19, typically induces
atypical pneumonia in humans by replicating in the lower and upper respiratory tract. It may …

Background: Coronavirus disease 2019 (COVID-19) has rapidly spread worldwide, but safe
and effective treatment options remain unavailable. Numerous systematic reviews of varying …

The study aimed to evaluate severe COVID-19 treatment approaches. We conducted a meta-
analysis of randomized controlled trials (RTCs) with standard of care (SoC) as a control …

Currently, there is no approved therapy for coronavirus disease 2019 (COVID-19). The
World Health Organization (WHO) therefore endorses supportive care only. However …

The novel coronavirus SARS-COV-2 or COVID-19 was first discovered in Wuhan, China in
late December 2019 and soon became a global pandemic. The virus causes flu-like …

Purpose: A number of research articles has been published evaluating safety and efficacy of
drugs against COVID-19. This study was undertaken to collate and review the information …

Objectives: Coronavirus pandemic is currently a global public health emergency. With
expanding knowledge of the virus and the disease, new therapeutic targets are emerging …